Prevalence of HPV-16 and 52 genotype in 2022-2023 in Sanandaj, Iran | Virology Magazine

  • Szymonowicz KA, Chen J. Biological and clinical aspects of HPV-related cancers. Biological medicine against cancer. 2020;17(4):864.

    Article CAS PubMed PubMed Central Google Scholar

  • Martinelli M, Musumeci R, Sechi I, Sotgiu G, Piana A, Perdoni F, et al. Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIs) among Italian women referred for colposcopy. Int J Environ Res Public Health. 2019;16(24):5000.

    Article PubMed PubMed Central Google Scholar

  • Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynecologist. 2020;40(5):602–8.

    CAS Article PubMed Google Scholar

  • Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global cervical cancer incidence and mortality estimates in 2020: a baseline analysis from the WHO global cervical cancer elimination initiative. Lancet Glob Health. 2023;11(2):e197–206.

    CAS Article PubMed Google Scholar

  • Anjam Majoumerd A, Hosseini S, Hosseini SM, Roshandel G, Rahmanian V, Hazar N. Epidemiology of cervical cancer in Iran in 2016: a national study of incidence and regional variation. Cancer Rep 2024;7(2):e1973.

  • Salavatiha Z, Farahmand M, Shoja Z, Jalilvand S. A meta-analysis of the prevalence and types of human papillomavirus among Iranian women with normal cervical cytology, premalignant lesions and cervical cancer. J Med Virol. 2021;93(8):4647–58.

    CAS Article PubMed Google Scholar

  • Macedo AC, Grande AJ, Figueiredo T, Colonetti T, Gonçalves JC, Testoni E, et al. Testing for high-risk HPV DNA, HPV mRNA, and P16 for the diagnosis of anal cancer and precursor lesions: a systematic review and meta-analysis. EClin Med. 2023:62.

  • Ashrafganjoei T, Hosseini MS, Pirastehfar Z, Farzaneh F, Arab M, Moghaddam NA, et al. Evaluation of anal cytology and human papillomavirus infection in high-risk women: a cross-sectional study. Med J Indonesia. 2022;31(4):245–9.

    Google Scholar Article

  • Sabatini ME, Chiocca S. Human papillomavirus as a driver of head and neck cancers. HJ Cancer. 2020;122(3):306–14.

    Article PubMed Google Scholar

  • Habibi L, Farzi R, Pirbonyeh N, Edalat F, Letafati A, Moattari A. Correlation between sampling site and human papillomavirus (HPV) prevalence in oral cancer patients referred to Shiraz, Iran. International of Oral Sciences.

  • Rezaee Azhar I, Yaghoobi M, Mossalaeie MM, Kollaee Darabi A, Nejadeh AH, Jamshidi M, et al. Prevalence of human papillomavirus (HPV) genotypes among male and female outpatients referred to seven laboratories in Tehran. Cancer infecting agents will go. 2022;17(1):7.

    Google Scholar Article

  • Seyoum A, Seyoum B, Gure T, Alemu A, Alemayehu DH, Alemu A, et al. A high rate of non-vaccine-targeted high-risk HPV genotypes circulates among women in eastern Ethiopia. Scientific Rep 2024;14(1):958.

    Article CAS PubMed PubMed Central Google Scholar

  • Han C, Huang W, Ye M, Zou R, Lan J, Chen J, et al. HPV prevalence and genotype distribution in 2306 patients with cervical squamous cell carcinoma in central and eastern China. Public Health Front. 2023:11.

  • Derbie A, Mekonnen D, Nibret E, Maier M, Woldeamanuel Y, Abebe T. Human papillomavirus genotype distribution in Ethiopia: an updated systematic review. Virol J. 2022;19(1):13.

    Article PubMed PubMed Central Google Scholar

  • Dionne M, Sauvageau C, Kiely M, Dahhou M, Hamel D, Rathwell M, et al. HPV and hepatitis B school vaccination program: a longitudinal analysis of vaccination coverage between 2015 and 2021 in Quebec. Vaccine. 2024;42(1):17–23.

    Article PubMed Google Scholar

  • Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modeling analysis in 78 low- and lower-middle-income countries. Lancet. 2020;395(10224):575–90.

    Article PubMed PubMed Central Google Scholar

  • Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bunda GA, Zhou Y, et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis and vaccine evaluation. Public Health Front. 2021;8:552028.

    Article PubMed PubMed Central Google Scholar

  • Farahmand Z, Soleimanjahi H, Garshasbi M, Hasanzadeh M, Zafari E. Distribution of the most common HPV types in Iranian women with and without cervical cancer. Women’s Health. 2021;61(1):73–82.

    Article PubMed Google Scholar

  • Okoye JO, Chukwukelu CF, Okekpa SI, Ogenyi SI, Onyekachi-Umah IN, Ngokere AA. Racial disparities associated with the prevalence of vaccinated and unvaccinated HPV types and multiple HPV infections between Asia and Africa: a systematic review and meta-analysis. J Cancer Prevention in Asia Pacific: APJCP. 2021;22(9):2729.

    CAS Article Google Scholar

  • Yousif MG, Al-Amran FG, Sadeq AM, Yousif NG. Prevalence and associated factors of human papillomavirus infection among Iraqi women. arXiv preprint arXiv:2307.14806. 2023.

  • Alacam S, Bakir A. Human papillomavirus prevalence and genotype distribution in cervical swab samples in Istanbul, Turkey. J Infect Develop Count. 2021;15(08):1190–6.

    CAS Article Google Scholar

  • Li X, Xiang F, Dai J, Zhang T, Chen Z, Zhang M, et al. Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China. Virol J. 2022;19(1):146.

    Article PubMed PubMed Central Google Scholar

  • Bruni L, Albero G, Rowley J, Alemany L, Arbyn M, Giuliano AR, et al. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Glob Health. 2023;11(9):e1345–e62.

    Article CAS PubMed PubMed Central Google Scholar

  • Garolla A, Graziani A, Grande G, Ortolani C, Ferlin A. HPV-related diseases in male patients: an underestimated enigma. J Endocrinol invest. 2024;47(2):261–74.

  • Lewis RM, Laprise JF, Gargano JW, Unger ER, Querec TD, Chesson HW, et al. Estimated prevalence and incidence of disease-associated human papillomavirus types among persons aged 15 to 59 years in the United States. Sexually transmitted disease. 2021;48(4):273–7.

    Article PubMed PubMed Central Google Scholar

  • Zhou YX, Ma XH, Wang TT, Qu XL, Zhang XQ. Analysis of the age and genotype distribution of multiple HPV infections in the Chinese population. Scientific Rep 2024;14(1):2678.

    Article CAS PubMed PubMed Central Google Scholar

  • Khoo SP, Bhoo-Pathy N, Yap SH, Shafii MK, Nasir NH, Belinson J, Subramaniam S, Goh PP, Zeng M, Tan HD, Gravitt P. Prevalence and sociodemographic correlates of cervicovaginal human papillomavirus (HPV) carriage on a cross -Sectional, multi-ethnic and community-based Asian female population. Sexually transmitted infection. 2018;94(4):277–83.

  • Huang W, Xu H, Hu H, Zhang D, Liu Y, Guo Y, et al. The prevalence of human papillomavirus among women in northern China’s Guangdong Province. Scientific Rep 2022;12(1):13353.

    Article CAS PubMed PubMed Central Google Scholar

  • Ong SK, Abe SK, Thilagaratnam S, Haruyama R, Pathak R, Jayasekara H, Togawa K, Bhandari AK, Shankar A, Nessa A, Jugder U. Towards elimination of cervical cancer: human papillomavirus vaccination (HPV) and cervical cancer screening in member countries of the Asian Alliance of National Cancer Centers (ANCCA). Lancet Reg Health West Pac. 2023;39.

  • Gollu AN, Gore CA. Knowledge, awareness and attitude of medical students towards HPV infection and HPV vaccination. Cancer Care Asia Pacific J. 2021;6(1):41–6.

    Google Scholar Article

  • Ruan Y, Li H, Liu M, Cao G, Xu X, Han L, et al. A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China, revealed the limitations of current HPV-based screening tests and HPV vaccination. Cancer Epidemiol. 2023;84:102372.

    Article PubMed Google Scholar

  • Sabet F, Mosavat A, Ghezeldasht SA, Basharkhah S, Shamsian SAA, Abbasnia S, et al. Prevalence, genotypes and phylogenetic analysis of human papillomaviruses (HPV) in northeastern Iran. Int J Infect Dis. 2021;103:480–8.

    CAS Article PubMed Google Scholar

  • Bahramabadi R, Honarvar Z, Iranpour M, Arababadi MK, Dehesh T, Dabiri B, et al. Epidemiological study of various HPV strains in cervical fluid samples in southeastern Iran, 2018-2020. Iran Med Archive 2021;24(9):678–83.

    Google Scholar Article

  • Shalchimanesh Z, Ghane M, Kalantar E. Prevalence of human papillomavirus genotypes in Tehran. Iran J Res Health Sciences. 2022;22(3)

  • Wang Y, Meng Y, Li W, Zhang X, Deng Z, Hu M, et al. Prevalence and characteristics of hrHPV infection among 414,540 women: a multicenter study in central and eastern China. J Cancer. 2019;10(8):1902.

    Article PubMed PubMed Central Google Scholar

  • Moossavi M, Fereidouni M, Zardast M, Khazaei Z, Ghanbarzadeh N. Human papillomavirus genotype distribution among women with genital wart biopsies in southern Khorasan, eastern Iran. Metagen. 2020;25:100720.

    Google Scholar Article

  • Xia C, Li S, Long T, Chen Z, Chan PK, Boon SS. Current updates on the types of human papillomavirus (HPV) that cause cancer in East, Southeast and South Asia. Cancers. 2021;13(11):2691.

    Article CAS PubMed PubMed Central Google Scholar

  • Kesheh MM, Keyvani H. The prevalence of HPV genotypes in the Iranian population: an update. Iran J. Pathol. 2019;14(3):197.

    Google Scholar Article

  • Fogarasi AI, Benczik M, Moravcsik-Kornyicki Á, Kocsis A, Gyulai A, Kósa Z. The prevalence of high-risk human papillomavirus in Hungary: a geographical representation. Cross-sectional study Pathol Oncol Res. 2022;28:1610424.

    Google Scholar Article

  • Tang X, Jones TE, Jiang W, Austin M, He Y, Li L, et al. Widespread distribution of human papillomavirus genotype in cervical intraepithelial neoplasia and cancer: analysis of 40,352 cases from a large academic gynecological center in China. J Med Virol. 2023;95(1):e28302.

    CAS Article PubMed Google Scholar